
201 - 500 employees
đ„ Healthcare
đ Manufacturing
âïž Healthcare Insurance
Healthcare âą Manufacturing âą Healthcare Insurance
Sirtex Medical Limited is a global healthcare company specializing in targeted and innovative solutions for liver cancer treatment. The company is known for its SIR-Spheres Y-90 resin microspheres, which are approved for the treatment of unresectable hepatic cancers, including hepatocellular carcinoma (HCC) and metastatic liver tumors from colorectal cancer. Sirtex operates in multiple regions including Asia Pacific, Australia, Europe, the United States, Brazil, and Latin America. The company is dedicated to supporting healthcare professionals and patients with advanced therapeutic products and comprehensive educational resources.
đĄ We watch Sirtex Medical Limited's careers page
Every hour
how often we check
3
roles posted in the last 30 days
About 28 days
usual time to fill a role
15
roles closed in the last year
Selected: đ Date Added.
đ„ 2 hours ago
Key Account Manager growing Sirtexâs targeted liver-cancer therapy across northeastern France. Managing hospital accounts, physician education, product adoption, and reimbursement negotiations.
đ«đ· France â Remote
â° Full Time
đĄ Mid-level
đ Senior
đ° Account Manager
đ» Ghost score 10%
đŁïžđ«đ· French Required
đ October 9
Medical affairs operations specialist managing grants, clinical studies, budgets, and physician programs. Supporting Sirtex Medicalâs global minimally invasive cancer and embolization therapies.
đ Massachusetts â Remote
đ” $76k - $110k / year
â° Full Time
đ Senior
âïž Operations
đ» Ghost score 0%
đ October 2
Medical and Clinical Affairs Operations Specialist managing grants, research, budgets, and physician programs. Supporting Sirtex Medicalâs minimally invasive cancer and embolization therapies.
đ Massachusetts â Remote
đ” $76k - $95k / year
â° Full Time
đĄ Mid-level
đ Senior
âïž Operations
đ» Ghost score 0%
đ September 18
Sales Director leading Regional Sales Managers and Area Sales Representatives for Sirtex Medical. Driving commercial growth for minimally invasive cancer and embolization therapies.